Metabolism, Inborn Errors

15 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Metabolic Diseases

Narrower: Adrenal Hyperplasia, Congenital 1, Glycogen Storage Disease Type I 1, Hemochromatosis 1, Homozygous Familial Hypercholesterolemia 2, Hyperlipoproteinemia Type I 1, Hyperlipoproteinemia Type II 4, Hyperlipoproteinemia Type V 1, Hypophosphatasia 1, Lysosomal Storage Diseases 1, Propionic Acidemia 1

Treatments and conditions

Metabolism, Inborn Errors
Treatment and conditionWhere it standsTrials
BBI-001 for hemochromatosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
BEAM-301: Single dose of BEAM-301 administered by IV for glycogen storage disease type iPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
CTX310 for homozygous familial hypercholesterolemiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
CTX310 for hyperlipoproteinemia type vPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Efzimfotase Alfa for hypophosphatasiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Enlicitide Decanoate for hyperlipoproteinemia type iiPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
mRNA-3927 for propionic acidemiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Olezarsen for hyperlipoproteinemia type iPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Osilodrostat for adrenal hyperplasia, congenitalPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 1 Dose Level 1 + Phase 1 Dose Level 2 + Phase 1 Dose Level 3 for metabolism, inborn errorsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 2 Established Dose from prior study, NCT03810196 for metabolism, inborn errorsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 2 Maximum Tolerated Dose determined in Phase 1 for metabolism, inborn errorsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
RP-A501 for lysosomal storage diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
SHR-1918 for homozygous familial hypercholesterolemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
VERVE-102 for hyperlipoproteinemia type iiPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.